FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900168537> ?p ?o ?g. }

• W2900168537 endingPage "332" @default.
• W2900168537 startingPage "319" @default.
• W2900168537 abstract "Animal preparations have revealed that moderate synaptic release of serotonin (5-HT) onto motoneurones enhances motor activity via activation of 5-HT2 receptors, whereas intense release of 5-HT causes spillover of 5-HT to extrasynaptic 5-HT1A receptors on the axon initial segment to reduce motoneurone activity. We explored if increasing extracellular concentrations of endogenously released 5-HT (via the selective serotonin reuptake inhibitor paroxetine) influences the ability to perform unfatigued and fatigued maximal voluntary contractions in humans. Following the ingestion of paroxetine, voluntary muscle activation and torque generation increased during brief unfatigued maximal contractions. In contrast, the ability to generate maximal torque with increased 5-HT availability was compromised under fatigued conditions, which was consistent with paroxetine-induced reductions in motoneurone excitability and voluntary muscle activation. This is the first in vivo human study to provide evidence that 5-HT released onto the motoneurones could play a role in central fatigue.Brief stimulation of the raphe-spinal pathway in the turtle spinal cord releases serotonin (5-HT) onto motoneurones to enhance excitability. However, intense release of 5-HT via prolonged stimulation results in 5-HT spillover to the motoneurone axon initial segment to activate inhibitory 5-HT1A receptors, thus providing a potential spinal mechanism for exercise-induced central fatigue. We examined how increased extracellular concentrations of 5-HT affect the ability to perform brief, as well as sustained, maximal voluntary contractions (MVCs) in humans. Paroxetine was used to enhance 5-HT concentrations by reuptake inhibition, and three studies were performed. Study 1 (n = 14) revealed that 5-HT reuptake inhibition caused an ∼4% increase in elbow flexion MVC. However, when maximal contractions were sustained, time-to-task failure was reduced and self-perceived fatigue was higher with enhanced availability of 5-HT. Study 2 (n = 11) used twitch interpolation to reveal that 5-HT-based changes in motor performance had a neural basis. Enhanced 5-HT availability increased voluntary activation for the unfatigued biceps brachii and decreased voluntary activation of the biceps brachii by 2-5% following repeated maximal elbow flexions. The final study (n = 8) investigated whether altered motoneurone excitability may contribute to 5-HT changes in voluntary activation. F-waves of the abductor digiti minimi (ADM) were unaffected by paroxetine for unfatigued muscle and marginally affected following a brief 2-s MVC. However, F-wave area and persistence were significantly decreased following a prolonged 60-s MVC of the ADM. Overall, high serotonergic drive provides a spinal mechanism by which higher concentrations of 5-HT may contribute to central fatigue." @default.
• W2900168537 created "2018-11-16" @default.
• W2900168537 creator A5017100702 @default.
• W2900168537 creator A5063956910 @default.
• W2900168537 creator A5090573061 @default.
• W2900168537 date "2018-11-08" @default.
• W2900168537 modified "2023-10-14" @default.
• W2900168537 title "Enhanced availability of serotonin increases activation of unfatigued muscle but exacerbates central fatigue during prolonged sustained contractions" @default.
• W2900168537 cites W1519977525 @default.
• W2900168537 cites W1629873406 @default.
• W2900168537 cites W1658373534 @default.
• W2900168537 cites W1882938085 @default.
• W2900168537 cites W1946245333 @default.
• W2900168537 cites W1963707158 @default.
• W2900168537 cites W1969126485 @default.
• W2900168537 cites W1976202125 @default.
• W2900168537 cites W1976431161 @default.
• W2900168537 cites W1981783120 @default.
• W2900168537 cites W1983346935 @default.
• W2900168537 cites W1983455339 @default.
• W2900168537 cites W1986878360 @default.
• W2900168537 cites W1995271633 @default.
• W2900168537 cites W1999175760 @default.
• W2900168537 cites W2002515362 @default.
• W2900168537 cites W2003294099 @default.
• W2900168537 cites W2032016599 @default.
• W2900168537 cites W2033606047 @default.
• W2900168537 cites W2045221789 @default.
• W2900168537 cites W2046262942 @default.
• W2900168537 cites W2051310888 @default.
• W2900168537 cites W2055929822 @default.
• W2900168537 cites W2065644002 @default.
• W2900168537 cites W2073361112 @default.
• W2900168537 cites W2074050752 @default.
• W2900168537 cites W2074861365 @default.
• W2900168537 cites W2076639163 @default.
• W2900168537 cites W2084579572 @default.
• W2900168537 cites W2093708977 @default.
• W2900168537 cites W2097918910 @default.
• W2900168537 cites W2110671072 @default.
• W2900168537 cites W2114111541 @default.
• W2900168537 cites W2122526337 @default.
• W2900168537 cites W2124474534 @default.
• W2900168537 cites W2130436598 @default.
• W2900168537 cites W2131288271 @default.
• W2900168537 cites W2134569977 @default.
• W2900168537 cites W2154554143 @default.
• W2900168537 cites W2165453261 @default.
• W2900168537 cites W2170132927 @default.
• W2900168537 cites W2179768144 @default.
• W2900168537 cites W2193494830 @default.
• W2900168537 cites W2333426586 @default.
• W2900168537 cites W2419532483 @default.
• W2900168537 cites W2513971625 @default.
• W2900168537 cites W2549621444 @default.
• W2900168537 cites W2740733628 @default.
• W2900168537 cites W2762141169 @default.
• W2900168537 cites W2783758664 @default.
• W2900168537 doi "https://doi.org/10.1113/jp277148" @default.
• W2900168537 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6312415" @default.
• W2900168537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30328105" @default.
• W2900168537 hasPublicationYear "2018" @default.
• W2900168537 type Work @default.
• W2900168537 sameAs 2900168537 @default.
• W2900168537 citedByCount "55" @default.
• W2900168537 countsByYear W29001685372018 @default.
• W2900168537 countsByYear W29001685372019 @default.
• W2900168537 countsByYear W29001685372020 @default.
• W2900168537 countsByYear W29001685372021 @default.
• W2900168537 countsByYear W29001685372022 @default.
• W2900168537 countsByYear W29001685372023 @default.
• W2900168537 crossrefType "journal-article" @default.
• W2900168537 hasAuthorship W2900168537A5017100702 @default.
• W2900168537 hasAuthorship W2900168537A5063956910 @default.
• W2900168537 hasAuthorship W2900168537A5090573061 @default.
• W2900168537 hasBestOaLocation W29001685371 @default.
• W2900168537 hasConcept C126322002 @default.
• W2900168537 hasConcept C134018914 @default.
• W2900168537 hasConcept C169760540 @default.
• W2900168537 hasConcept C170493617 @default.
• W2900168537 hasConcept C185592680 @default.
• W2900168537 hasConcept C24998067 @default.
• W2900168537 hasConcept C2775864247 @default.
• W2900168537 hasConcept C2777828372 @default.
• W2900168537 hasConcept C2777865548 @default.
• W2900168537 hasConcept C37000724 @default.
• W2900168537 hasConcept C53910766 @default.
• W2900168537 hasConcept C71924100 @default.
• W2900168537 hasConcept C86803240 @default.
• W2900168537 hasConceptScore W2900168537C126322002 @default.
• W2900168537 hasConceptScore W2900168537C134018914 @default.
• W2900168537 hasConceptScore W2900168537C169760540 @default.
• W2900168537 hasConceptScore W2900168537C170493617 @default.
• W2900168537 hasConceptScore W2900168537C185592680 @default.
• W2900168537 hasConceptScore W2900168537C24998067 @default.
• W2900168537 hasConceptScore W2900168537C2775864247 @default.
• W2900168537 hasConceptScore W2900168537C2777828372 @default.
• W2900168537 hasConceptScore W2900168537C2777865548 @default.

• next